Survey reveals young breast cancer Patients' fears about losing fertility
NCT ID NCT00062400
First seen Jun 04, 2026 · Last updated Jun 22, 2026 · Updated 4 times
Summary
This study surveyed 385 women aged 35 or younger with early-stage breast cancer to learn how they feel about the risk of infertility from chemotherapy. The goal was to understand whether they would still choose chemotherapy if it might reduce their chances of having children. The results could help doctors better support young patients in making treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, 1105 AZ, Netherlands
-
Algemeen Ziekenhuis Sint-Augustinus
Wilrijk, 2610, Belgium
-
American University of Beirut Medical Center
Beirut, 113-6044, Lebanon
-
Arnhems Radiotherapeutisch Instituut
Arnhem, 6815 AD, Netherlands
-
Azienda Istituti Ospitalieri
Cremona, 26100, Italy
-
CHU Liege - Domaine Universitaire du Sart Tilman
Liège, B-4000, Belgium
-
Centre Hospitalier Etterbeek Ixelles
Brussels, B-1050, Belgium
-
Centro di Riferimento Oncologico - Aviano
Aviano, 33081, Italy
-
Clinica Alemana
Santiago, 5951, Chile
-
European Institute of Oncology
Milan, 20141, Italy
-
Groote Schuur Hospital
Cape Town, 7925, South Africa
-
Hospital Militar
Santiago, Chile
-
Inselspital Bern
Bern, CH-3010, Switzerland
-
Institut Jules Bordet
Brussels, 1000, Belgium
-
Institute of Oncology and Radiology of Serbia
Belgrade, 11000, Serbia
-
Instituto Nacional de Enfermedades Neoplasicas
Lima, 34, Peru
-
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
Lisbon, 1099-023 Codex, Portugal
-
Instituto de Radiomedicina
Santiago, 10, Chile
-
Kantonsspital - St. Gallen
Sankt Gallen, CH-9007, Switzerland
-
Klinikum der J.W. Goethe Universitaet
Frankfurt, D-60590, Germany
-
Marmara University Hospital
Istanbul, 81190, Turkey (Türkiye)
-
Medical University of Gdansk
Gdansk, 80-211, Poland
-
Ospedale Alessandro Manzoni
Lecco, 23900, Italy
-
Ospedale Beata Vergine
Mendrisio, CH-6850, Switzerland
-
Universitatsklinikum Heidelberg
Heidelberg, 69115, Germany
-
University Hospital Rebro
Zagreb, 41000, Croatia
-
Western Infirmary
Glasgow, Scotland, G11 6NT, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better understand how to talk to young women about fertility risks when planning breast cancer treatment.
What could go wrong
This is a survey study, not a treatment trial. It gathers opinions, so it won't directly lead to new therapies or cures.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.